Showing results (2181-2190 of 8,157) with videos related to
Sort By:
Pageof 816
Haematologica|February 11, 2021
Sulfated non-anticoagulant heparin derivative modifies intracellular hemoglobin, inhibits cell sickling in vitro, and prolongs survival of sickle cell mice under hypoxiaOsheiza Abdulmalik, Noureldien H E Darwish, Vandhana Muralidharan-Chari, et al.Haematologica|March 18, 2017
Improved survival after acute graft-versus-host disease diagnosis in the modern eraHanna J Khoury, Tao Wang, Michael T Hemmer, et al.Haematologica|February 4, 2021
Mobilization efficiency is critically regulated by fat via marrow PPARδTomohide Suzuki, Shinichi Ishii, Masakazu Shinohara, et al.Haematologica|August 16, 2019
IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplificationPhaik Ju Teoh, Tae-Hoon Chung, Pamela Y Z Chng, et al.Haematologica|August 16, 2019
Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic womenNicole U Stoffel, Christophe Zeder, Gary M Brittenham, et al.Haematologica|August 16, 2019
Emerging disease-modifying therapies for sickle cell diseaseMarcus A Carden, Jane LittleHaematologica|January 14, 2021
Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cellsHannes Schmid, Emmanuelle M Ribeiro, Kathy-Ann Secker, et al.Haematologica|January 14, 2021
Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vectorYang Liu, Maria Dahl, Shubhranshu Debnath, et al.Haematologica|July 13, 2019
Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimensAnna Vidal-Crespo, Alba Matas-Céspedes, Vanina Rodriguez, et al.Haematologica|July 13, 2019
Dynamin 2 is required for GPVI signaling and platelet hemostatic function in miceNathan Eaton, Caleb Drew, Jon Wieser, et al.Pageof 816